MARS is a Recovery Community Support Program Grantee |
MARS is a Recovery Community Support Program Grantee |
October 9, 2002 NIDA Contact: Michelle Person 301-443-6245 SAMHSA Contact: Leah Young 301-443-8956 Buprenorphine, a new medication developed through more than a decade of research supported by the National Institute on Drug Abuse (NIDA), will now become available to treat heroin and other opioid dependence through certification and training of physicians to use the medication…
2004 2005 2006 2007 2009 2016
Sponsored by American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Saturday, April 12, 2003 Pre-Conference Session A Day of Methadone Advocacy Training NAMA Moves Methadone Advocacy to a New Level with training and certification. Includes a Photo Album of the Day and Jo L. Sotheran’s presentation on Working a…
Office Based Opioid Treatment Basic Information for Physicians About Buprenorphine Federal Law Code of Federal Regulations. Confidentiality of Alcohol and Drug Abuse Patient Records. 42 CRF Part 2. Read PDF File Document. Public Law 106-310, 106th Congress. Sec. 3502. Controlled Substances Act, October 17, 2000. Full Law Basic Information About DATA:On October 17, 2000…
NAMA Recovery does not presently have a webmaster. This site is being maintained by: Joycelyn Woods, M.A., C.M.A.: . Walter Ginter, C.M.A.: Do you have Programming Skills? NAMA Recovery needs a webmaster. It is volunteer and would require about 10 hours a week Contact Joycelyn Woods or Walter Ginter above. This website is best viewed…
American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Workshop April 15, 2003 Medication – Assisted Treatment in Different Practice Settings: Patients’ Perspectives Joycelyn Woods, National Alliance of Methadone Advocates, Facilitator NAMA representativees will discuss the administration of methadone in a variety of settings. Topics will include the patients’…